Nanomedicine lecture series: Nanotechnology in neurology and neurosciences, Thursday, 9 November 2017

Written by UMIP on . Posted in News

Our second lecture in the nanomedicine lecture series, to be held on Thursday, 9 November 2017 in UMIC’s Core Technology Facility Dalton Room, will focus on nanotechnology in neurology and neurosciences, exploring the bridge between technology and neuroscience.

Keynote speakers:

The following pre-eminent global leaders in biomedical science will be keynote speakers at this event:

  • Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester
  • Professor Ed Boyden, Associate Professor, Media Lab and McGovern Institute, Departments of Biological Engineering and Brain and Cognitive Sciences Co-Director, MIT Centre for Neurobiological Engineering
  • Professor John Hardy, University College London

Registration:

Please register via Eventbrite: https://www.eventbrite.co.uk/e/nanomednetwork-lecture-series-2-nanotechnology-in-neurologyneurosciences-tickets-34568005836

Please contact Sarah Barton (sarah.barton@manchester.ac.uk) in the FBMH Strategic Funding Team with any queries.

About the NanoMed Network:

The University of Manchester NanoMed Network is a cross-faculty interdisciplinary network that aims to facilitate the exploitation of novel nanomaterials and nanotechnologies, such as graphene and other 2D materials, in order to provide solutions for unmet clinical challenges.

NanoMed Network website.

UMIP - REPUTATION AND VALUE THROUGH INTELLECTUAL PROPERTY®

Privacy Policy / Terms and Conditions / © Copyright 2015 The University of Manchester Intellectual Property / Created by HTP Digital Marketing Agency

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.